HYDRACs are a class of proteomimetic polymers designed to mark harmful proteins, like MYC and KRAS, for destruction rather than merely block their activity.
A new strategy developed by Professor Nathan Gianneschi grabs cancer-driving proteins and directs them to the cell’s disposal ...
Study represents a significant advancement in Grove’s Bionic Biologics™ platform – CHICAGO--(BUSINESS WIRE)--February 24, 2026-- Grove Biopharma, ...
A team led by Professor Shoichiro Asayama at Tokyo Metropolitan University has synthesized a charge-free molecule designed to ...
When cancer-driving proteins resist various treatments, Northwestern University scientists have uncovered a new solution. Don ...
Brenntag Specialties has signed a distribution agreement with Nanum to supply graphene-based nanotechnology products in Brazil, expanding its Materials Science portfolio and strengthening its presence ...
LambdaVision, an innovative biotech company developing a protein-based artificial retina to help patients regain sight lost to retinal degenerative diseases, is advancing its commercialization efforts ...